IL86577A - Antibodies having specific affinity for autocrine motility factor, a kit containing the same, and use thereof to detect the presence of cancer in humans - Google Patents

Antibodies having specific affinity for autocrine motility factor, a kit containing the same, and use thereof to detect the presence of cancer in humans

Info

Publication number
IL86577A
IL86577A IL86577A IL8657788A IL86577A IL 86577 A IL86577 A IL 86577A IL 86577 A IL86577 A IL 86577A IL 8657788 A IL8657788 A IL 8657788A IL 86577 A IL86577 A IL 86577A
Authority
IL
Israel
Prior art keywords
antibodies
humans
cancer
detect
same
Prior art date
Application number
IL86577A
Other versions
IL86577A0 (en
Original Assignee
Us Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Commerce filed Critical Us Commerce
Publication of IL86577A0 publication Critical patent/IL86577A0/en
Publication of IL86577A publication Critical patent/IL86577A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3038—Kidney, bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015—Breast
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3053—Skin, nerves, brain
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G01N2333/4706—Regulators; Modulating activity stimulating, promoting or activating activity
IL86577A 1987-06-05 1988-05-31 Antibodies having specific affinity for autocrine motility factor, a kit containing the same, and use thereof to detect the presence of cancer in humans IL86577A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5838187A 1987-06-05 1987-06-05

Publications (2)

Publication Number Publication Date
IL86577A0 IL86577A0 (en) 1988-11-15
IL86577A true IL86577A (en) 1993-06-10

Family

ID=22016462

Family Applications (1)

Application Number Title Priority Date Filing Date
IL86577A IL86577A (en) 1987-06-05 1988-05-31 Antibodies having specific affinity for autocrine motility factor, a kit containing the same, and use thereof to detect the presence of cancer in humans

Country Status (6)

Country Link
EP (1) EP0362278A4 (en)
JP (1) JP2851288B2 (en)
AU (1) AU614755B2 (en)
CA (1) CA1310902C (en)
IL (1) IL86577A (en)
WO (1) WO1988009797A1 (en)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE455946B (en) * 1986-10-20 1988-08-22 Trion Forskning & Utveckling NEW PERTUSSISTOXIN POLYPEPTIDES AND ANTIGENS AND TEST KITS, VACCINES AND INTRADERMAL SKIN TEST COMPOSITIONS
US5449753A (en) * 1992-01-17 1995-09-12 The United States Of America As Represented By The Department Of Health And Human Services Autotaxin: motility stimulating protein useful in cancer diagnosis
US5382521A (en) * 1992-07-14 1995-01-17 Michigan Cancer Foundation Method of determining metastatic potential of bladder tumor cells
CA2238257A1 (en) * 1998-05-22 1999-11-22 Universite De Montreal Endocytosis of amf-r and uses thereof in cancer therapy
DE19847107A1 (en) * 1998-10-13 2000-04-20 Herbert Ruebben Use of pertussis toxin to prepare a pharmaceutical composition for treating tumors, especially carcinomas or sarcomas
KR100629028B1 (en) 1998-10-16 2006-09-26 글락소스미스클라인 바이오로지칼즈 에스.에이. Adjuvant systems and vaccines
WO2001074897A2 (en) * 2000-04-03 2001-10-11 Curagen Corporation Protein amf-1 to amf-10 and nucleic acids encoding the same
DE602005025342D1 (en) 2004-05-28 2011-01-27 Glaxosmithkline Biolog Sa VACCINE COMPOSITIONS WITH VIRUSOMES AND A SAPONIN ADJUVANS
CA2601022C (en) 2005-03-23 2023-03-07 Glaxosmithkline Biologicals S.A. Use of an influenza virus an oil-in-water emulsion adjuvant to induce cd4 t-cell and/or improved b-memory cell response
GB0519871D0 (en) 2005-09-30 2005-11-09 Secr Defence Immunogenic agents
TWI457133B (en) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa Novel composition
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
CA2816182C (en) 2005-12-22 2018-02-20 Glaxosmithkline Biologicals S.A. Pneumococcal polysaccharide conjugate vaccine
US20100021503A1 (en) 2006-03-30 2010-01-28 Glaxosmithkline Biologicals S.A. Immunogenic composition
CN105727276A (en) 2006-07-17 2016-07-06 葛兰素史密丝克莱恩生物有限公司 Influenza vaccine
AU2007276217B2 (en) 2006-07-18 2013-08-29 Glaxosmithkline Biologicals S.A. Vaccines for malaria
GB2453475B (en) 2006-07-25 2011-01-19 Secr Defence Live vaccine strain
EP2433648A3 (en) 2006-10-12 2012-04-04 GlaxoSmithKline Biologicals S.A. Vaccine comprising an oil in water emulsion adjuvant
BRPI0717219B8 (en) 2006-10-12 2021-05-25 Glaxosmithkline Biologicals Sa immunogenic composition, and, use of an immunogenic composition
AR066405A1 (en) 2007-04-20 2009-08-19 Glaxosmithkline Biolog Sa VACCINE
KR101579947B1 (en) 2007-06-26 2015-12-28 글락소스미스클라인 바이오로지칼즈 에스.에이. Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
AU2008352942B2 (en) 2007-12-19 2013-09-12 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Soluble forms of Hendra and Nipah virus F glycoprotein and uses thereof
MX2010011412A (en) 2008-04-16 2010-11-12 Glaxosmithkline Biolog Sa Vaccine.
GB0900455D0 (en) 2009-01-13 2009-02-11 Secr Defence Vaccine
GB0901423D0 (en) 2009-01-29 2009-03-11 Secr Defence Treatment
GB0901411D0 (en) 2009-01-29 2009-03-11 Secr Defence Treatment
GB0906234D0 (en) 2009-04-14 2009-05-20 Secr Defence Vaccine
GB0913680D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
GB0919117D0 (en) 2009-10-30 2009-12-16 Glaxosmithkline Biolog Sa Process
JP2013523617A (en) 2010-03-26 2013-06-17 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム HIV vaccine
GB201009273D0 (en) 2010-06-03 2010-07-21 Glaxosmithkline Biolog Sa Novel vaccine
GB201022007D0 (en) 2010-12-24 2011-02-02 Imp Innovations Ltd DNA-sensor
CN110680913A (en) 2011-05-13 2020-01-14 硕腾有限公司 Hendra and nipah virus G glycoprotein immunogenic compositions
CN103533953A (en) 2011-05-17 2014-01-22 葛兰素史密丝克莱恩生物有限公司 Vaccine against streptococcus pneumoniae
GB201119999D0 (en) 2011-11-20 2012-01-04 Glaxosmithkline Biolog Sa Vaccine
GB201120000D0 (en) 2011-11-20 2012-01-04 Glaxosmithkline Biolog Sa Vaccine
WO2014086787A1 (en) 2012-12-05 2014-06-12 Glaxosmithkline Biologicals S.A. Immunogenic composition
CN104436157A (en) 2013-09-23 2015-03-25 恩金生物有限公司 Influenza vaccine and therapy
EP3082856A1 (en) 2013-12-16 2016-10-26 Zoetis Services LLC Hendra and nipah virus g glycoprotein immunogenic compositions
LT3160500T (en) 2014-06-25 2019-10-25 Glaxosmithkline Biologicals Sa Clostridium difficile immunogenic composition
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
GB201616904D0 (en) 2016-10-05 2016-11-16 Glaxosmithkline Biologicals Sa Vaccine
EP3615061A1 (en) 2017-04-28 2020-03-04 GlaxoSmithKline Biologicals S.A. Vaccination
GB201707700D0 (en) 2017-05-12 2017-06-28 Glaxosmithkline Biologicals Sa Dried composition
IE20190086A1 (en) 2017-05-30 2019-12-25 Glaxosmithkline Biologicals Sa Novel methods for manufacturing an adjuvant
EP3581201A1 (en) 2018-06-15 2019-12-18 GlaxoSmithKline Biologicals S.A. Escherichia coli o157:h7 proteins and uses thereof
WO2019245266A1 (en) * 2018-06-20 2019-12-26 박희성 Anti-cancer composition comprising cancer-derived amf as active ingredient
MX2021001129A (en) 2018-07-31 2021-07-02 Glaxosmithkline Biologicals Sa Antigen purification method.
US11547672B2 (en) 2018-09-14 2023-01-10 Massachusetts Institute Of Technology Nanoparticle vaccine adjuvant and methods of use thereof
US20220339282A1 (en) 2018-11-29 2022-10-27 Glaxosmithkline Biologicals Sa Methods for manufacturing an adjuvant
WO2020190959A1 (en) 2019-03-19 2020-09-24 The Uab Research Foundation Saponin-based vaccine adjuvants
EP3777884A1 (en) 2019-08-15 2021-02-17 GlaxoSmithKline Biologicals S.A. Immunogenic composition
JP2022547298A (en) 2019-09-09 2022-11-11 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム immunotherapeutic composition
US20220387614A1 (en) 2019-11-22 2022-12-08 Glaxosmithkline Biologicals Sa Dosage and administration of a bacterial saccharide glycoconjugate vaccine
WO2021122551A1 (en) 2019-12-19 2021-06-24 Glaxosmithkline Biologicals Sa S. aureus antigens and compositions thereof
WO2021224205A1 (en) 2020-05-05 2021-11-11 Glaxosmithkline Biologicals Sa Microfluidic mixing device and methods of use
WO2022029024A1 (en) 2020-08-03 2022-02-10 Glaxosmithkline Biologicals Sa Truncated fusobacterium nucleatum fusobacterium adhesin a (fada) protein and immunogenic compositios thereof
WO2022072431A1 (en) 2020-09-30 2022-04-07 Zoetis Services Llc Novel pasteurella multocida strains and vaccines having hyac and nanp deletions
AU2021392894A1 (en) 2020-12-02 2023-06-29 Glaxosmithkline Biologicals Sa Donor strand complemented fimh
WO2023020994A1 (en) 2021-08-16 2023-02-23 Glaxosmithkline Biologicals Sa Novel methods
WO2023020993A1 (en) 2021-08-16 2023-02-23 Glaxosmithkline Biologicals Sa Novel methods
WO2023020992A1 (en) 2021-08-16 2023-02-23 Glaxosmithkline Biologicals Sa Novel methods
US20230190920A1 (en) 2021-12-19 2023-06-22 Massachusetts Institute Of Technology Compositions and methods for long-lasting germinal center responses to a priming immunization
WO2023175454A1 (en) 2022-03-14 2023-09-21 Pfizer Inc. Methods for producing an adjuvant

Also Published As

Publication number Publication date
EP0362278A4 (en) 1990-05-14
IL86577A0 (en) 1988-11-15
CA1310902C (en) 1992-12-01
AU614755B2 (en) 1991-09-12
AU1803488A (en) 1989-01-04
JPH04502143A (en) 1992-04-16
JP2851288B2 (en) 1999-01-27
WO1988009797A1 (en) 1988-12-15
EP0362278A1 (en) 1990-04-11

Similar Documents

Publication Publication Date Title
IL86577A (en) Antibodies having specific affinity for autocrine motility factor, a kit containing the same, and use thereof to detect the presence of cancer in humans
EP0323055A3 (en) Composition chromatographic article
GB8905669D0 (en) Modified antibodies
IL78993A0 (en) Antibodies and kit for use in radiotherapy and radioimmunoassay utilizing the same
GR890300071T1 (en) Improvements in or relating to hormones
IL84160A0 (en) Method and kit for immune complex assay
EP0285511A3 (en) Monoclonal antibodies and their uses
IL87730A0 (en) Peptides and antibodies
GB8822738D0 (en) Theophylline assay
GR910300146T1 (en) Grenade for multi-purpose use
GB8902771D0 (en) Improvements in or relating to affinity chromatography
GB8716818D0 (en) Pen
GB9014409D0 (en) Compact pen
GB8920375D0 (en) Improvements in or relating to piston rings
EP0381763A4 (en) Antibody modified with toxin
GB8910912D0 (en) Improvements in or relating to ring binder mechanisms
HU896324D0 (en) Peptides binding to antibody
HU896325D0 (en) Peptides binding to antibody
GB9125997D0 (en) Toxin uses
GB8909129D0 (en) Multi-purpose bookrest
GB8907576D0 (en) Improvements relating to biosensors
GB8812137D0 (en) Antibodies
GB8805240D0 (en) Improvements relating to antigen
GB8618160D0 (en) Elongate articles antibodies
GB8804464D0 (en) Improvements in/relating to antibodies

Legal Events

Date Code Title Description
KB Patent renewed
RH Patent void
KB Patent renewed
KB Patent renewed
EXP Patent expired